Your browser doesn't support javascript.
loading
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease.
Vega, Gloria L; Wang, Jijia; Grundy, Scott M.
Afiliação
  • Vega GL; Center for Human Nutrition; Clinical Nutrition; Applied Clinical Research, University of Texas Southwestern Medical Center; The Veterans Administration North Texas Healthcare System, Dallas, Texas. Electronic address: Gloria.Vega@utsouthwestern.edu.
  • Wang J; Applied Clinical Research, University of Texas Southwestern Medical Center.
  • Grundy SM; Center for Human Nutrition; Departments of Internal Medicine; Applied Clinical Research, University of Texas Southwestern Medical Center; The Veterans Administration North Texas Healthcare System, Dallas, Texas. Electronic address: Scott.Grundy@utsouthwestern.edu.
J Clin Lipidol ; 16(1): 66-74, 2022.
Article em En | MEDLINE | ID: mdl-34922882
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose Tipo de estudo: Etiology_studies / Guideline / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: J Clin Lipidol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Aterosclerose Tipo de estudo: Etiology_studies / Guideline / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: J Clin Lipidol Ano de publicação: 2022 Tipo de documento: Article